The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face ...
Stifel downgraded LVMH (LVMUY) to Hold from Buy with a price target of EUR 710, up from EUR 680. The firm says the company’s lack of earnings ...
Stifel analysts led by Rogerio Fujimori downgraded LVMH stock from a "Buy" to a "Hold" rating, while simultaneously raising the price target to €710 from the previous €680. The adjustment comes ...
Barclays lowered the firm’s price target on LVMH (LVMUY) to EUR 780 from EUR 7,770 and keeps an Overweight rating on the shares.Maximize Your ...